Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea

NCT: NCT07711678 · NOT_YET_RECRUITING

NCT IDNCT07711678
StatusNOT_YET_RECRUITING
Start Date2026-07-15
Completion2027-02-28
SponsorBeijing Pins Medical Co., Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the safety and preliminary effectiveness of an implantable hypoglossal nerve stimulation system for moderate-to-severe obstructive sleep apnea (OSA).

Frequently Asked Questions

What is Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea?

Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea is a clinical trial registered under NCT07711678. Current status: NOT_YET_RECRUITING.

What is the status of NCT07711678?

The current status of NCT07711678 (Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea) is: NOT_YET_RECRUITING.

When did Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea start?

Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea started on 2026-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑